A 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naph thyridine-3-carboxylic acid DMF (Drug Master File) is a document detailing the whole manufacturing process of 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naph thyridine-3-carboxylic acid active pharmaceutical ingredient (API) in detail. Different forms of 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naph thyridine-3-carboxylic acid DMFs exist exist since differing nations have different regulations, such as 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naph thyridine-3-carboxylic acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naph thyridine-3-carboxylic acid DMF submitted to regulatory agencies in the US is known as a USDMF. 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naph thyridine-3-carboxylic acid USDMF includes data on 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naph thyridine-3-carboxylic acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naph thyridine-3-carboxylic acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naph thyridine-3-carboxylic acid suppliers with USDMF on PharmaCompass.